 Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: Cohort study of persistent neuropathy among early breast cancer survivors

Br J Cancer: Cohort study of persistent neuropathy among early breast cancer survivors

 Last Update: 2021-06-01
 Source: Internet
 Author: User

Tags

data collection strategies

3 4 dimethoxybenzaldehyde

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Globally, breast cancer is one of the most common cancers in women.

Breast cancer Early breast cancer (ESBC) patients have a good prognosis, but the risk of long-term adverse events must also be considered.

The treatment of ESBC includes paclitaxel chemotherapy, which is a treatment strategy closely related to peripheral neuropathy (PN).

The prevalence of persistent peripheral neuropathy (PN) in ESBC surviving patients is currently unclear.

This study aims to investigate the occurrence of PN and related risk factors in long-term ESBC survivors undergoing paclitaxel chemotherapy.

Related research flow chart

The results showed that the remission rate of survivors was 79% and that of the control group was 59%.

EORTC QLQ-CIPN20 data analysis of early breast cancer survivors and control women

All in all, the results of the study revealed that compared to normal women, PN is more common in ESBC survivors, and many symptoms persist over time.

The results of the study revealed that compared with normal women, PN is more common in ESBC survivors, and many symptoms persist over time.

org/10.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.